Differential CARM1 expression in prostate and colorectal cancers.
about
Arginine methyltransferases as novel therapeutic targets for breast cancerThe role of testosterone in colorectal carcinoma: pathomechanisms and open questionsThe role of epigenetics in resistance to Cisplatin chemotherapy in lung cancerPRMT8 demonstrates variant-specific expression in cancer cells and correlates with patient survival in breast, ovarian and gastric cancer.Epigenetics: an emerging player in gastric cancerGlobal mapping of CARM1 substrates defines enzyme specificity and substrate recognition.Coregulator cell cycle and apoptosis regulator 1 (CCAR1) positively regulates adipocyte differentiation through the glucocorticoid signaling pathwayCARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells.A coactivator role of CARM1 in the dysregulation of β-catenin activity in colorectal cancer cell growth and gene expression.Mutations in epigenetic modifiers in myeloid malignancies and the prospect of novel epigenetic-targeted therapyProtein arginine methyltransferase 7 promotes breast cancer cell invasion through the induction of MMP9 expressionDifferential CARM1 Isoform Expression in Subcellular Compartments and among Malignant and Benign Breast Tumors.Chemical biology of protein arginine modifications in epigenetic regulationAlternatively spliced protein arginine methyltransferase 1 isoform PRMT1v2 promotes the survival and invasiveness of breast cancer cells.A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases.Expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1 (CARM1), is associated with specific breast cancer subtypes and ethnicity.Overexpression of CARM1 in breast cancer is correlated with poorly characterized clinicopathologic parameters and molecular subtypes.miR-195 enhances the radiosensitivity of colorectal cancer cells by suppressing CARM1.Promises and challenges of anticancer drugs that target the epigenome.Protein arginine methyltransferases (PRMTs) as therapeutic targets.Role of PRMTs in cancer: Could minor isoforms be leaving a mark?Histone modifying enzymes: novel disease biomarkers and assay development.Site-specific methylation of Notch1 controls the amplitude and duration of the Notch1 response.Identification of the PRMT1v1 and PRMT1v2 specific interactomes by quantitative mass spectrometry in breast cancer cells.Protein arginine methylation/demethylation and cancer.Design and synthesis of selective, small molecule inhibitors of coactivator-associated arginine methyltransferase 1 (CARM1).The Overexpression of CARM1 Promotes Human Osteosarcoma Cell Proliferation through the pGSK3β/β-Catenin/cyclinD1 Signaling Pathway.Transition state mimics are valuable mechanistic probes for structural studies with the arginine methyltransferase CARM1.Discovery of a Potent, Selective, and Cell-Active Dual Inhibitor of Protein Arginine Methyltransferase 4 and Protein Arginine Methyltransferase 6.Labeling substrates of protein arginine methyltransferase with engineered enzymes and matched S-adenosyl-L-methionine analoguesA fast approach to detect gene-gene synergy.CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity.TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma.The prognostic significance of protein arginine methyltransferase 6 expression in colon cancer.Cancer-related transcription regulator protein NAC1 forms a protein complex with CARM1 for ovarian cancer progression.
P2860
Q26851594-9EF1BDEF-37FB-4CA3-BBA2-B447BBEA29CBQ28077795-2D6A4C3D-FFCD-4349-9C6C-B64AED06455BQ28387891-29BADA81-A401-42BC-94A4-079747292FC2Q33599084-1ADA9433-6705-4D0D-BC19-082AC20CF0F8Q33718259-056653B1-E3D5-46AB-BE16-EDEA08D10D57Q33761232-958754B6-3E0E-491C-BF7B-1091FA891CFBQ33761295-BAF124C0-4801-46A8-89B6-A1FA5DEFDD50Q34794245-1588E187-56AB-4B39-AF6C-1907728BC190Q34987904-0F5DE487-CA46-4D47-A0E0-31BBC6D39BE7Q35132953-354582B2-CA16-4A62-84D8-C09A405942A8Q35550160-050F9E79-6DDE-4A52-963D-6310AF5311C2Q35673016-358144E4-1ACD-49C1-941A-13FE8C044D38Q35722457-93FC1C6F-8A33-4F47-B085-BC3F6CBEE48CQ36581678-88488EED-76F0-4201-AA99-8EAC072988BFQ36703511-380F9684-610B-4E07-9D47-73984F8E7C0EQ36874135-22301277-B849-4340-9748-A2EBB14DDD79Q37153775-F1AC2692-9A7D-4EFE-8472-3B6801B1818BQ37664798-821259E9-9B9E-4C97-BA1F-30A1B05D267EQ37962596-A8DE2CC5-FCDE-491B-AE0E-F8AEC9A2694CQ38012526-2DCEE985-D6D0-4AC8-A382-03405557BECFQ38219647-F17ED0BA-D7DB-4E4C-8193-19E2FC2566BBQ38691865-34861206-CF3E-4F33-8FB4-2A29B036D0EDQ38895538-D6D78B40-10C3-4CDA-ABC2-C0E617DFCC7BQ38908624-DB6F0DAC-20F4-4CF6-B21A-3E639C55730CQ38935888-6BC1D152-979B-4D9B-8931-FD309258A88DQ40269933-B05D989C-94B9-4603-AF62-D5A21D1D56F9Q41036174-E153E09A-D50A-4C69-B321-C6C3B45EF381Q42130155-F9DC5650-0D25-4C44-8AD1-95BA0F85DD1CQ42383290-BFB5D18D-80C5-4144-8CEA-CF3644CEFAB0Q42741100-1D78F2F4-74F2-48AB-89E8-E7B4320F8523Q47309011-14022458-5728-4688-8164-EE1C2D8DF450Q50055585-19773F51-BB27-4B73-96D9-AF2E176A7222Q52714602-B8CA8DC0-907A-4770-95AF-02D70991EDD0Q55003970-15D9BB78-6E7F-4825-B071-A63CD5253454Q55504453-CE2B09B6-00BF-4DDB-9A36-A33A8109D51B
P2860
Differential CARM1 expression in prostate and colorectal cancers.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Differential CARM1 expression in prostate and colorectal cancers.
@ast
Differential CARM1 expression in prostate and colorectal cancers.
@en
Differential CARM1 expression in prostate and colorectal cancers.
@nl
type
label
Differential CARM1 expression in prostate and colorectal cancers.
@ast
Differential CARM1 expression in prostate and colorectal cancers.
@en
Differential CARM1 expression in prostate and colorectal cancers.
@nl
prefLabel
Differential CARM1 expression in prostate and colorectal cancers.
@ast
Differential CARM1 expression in prostate and colorectal cancers.
@en
Differential CARM1 expression in prostate and colorectal cancers.
@nl
P2093
P2860
P356
P1433
P1476
Differential CARM1 expression in prostate and colorectal cancers.
@en
P2093
Byung Kook Lee
Chaeyong Jung
Dong Deuk Kwon
Jeong A Bae
Nguyen Thi Xuan Nguyen
Ra-Young Park
Young-Rang Kim
P2860
P2888
P356
10.1186/1471-2407-10-197
P407
P577
2010-05-13T00:00:00Z
P5875
P6179
1009941669